EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy

Status Recruiting

Clinical Trial Summary

Objectives Acute cholecystitis commonly occurs in elderly patients who are at high-risk for surgery. Whether upfront Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is advantageous over antibiotics first for mild acute cholecystitis is uncertain. Hypothesis to be tested The aim is to compare EUS-GBD versus standard protocol (antibiotics first) as a definitive treatment, in very high-risk patients suffering from mild to moderate acute cholecystitis. We hypothesize that EUS-GBD can reduce the 1-year risk of recurrent acute cholecystitis. Design and subjects This is an international randomised controlled study including consecutive patients suffering from acute cholecystitis that are very high-risk for cholecystectomy. The patients would be randomized to receive EUS-GBD or antibiotics first. Interventions: EUS-GBD versus antibiotics Main outcome measures: The primary outcome is the rate of recurrent acute cholecystitis in 1 year. Other outcomes include technical and clinical success, post-procedural pain scores, analgesic requirements, adverse events, re-admissions, re-interventions, quality of life and cost analysis. Data analysis All outcomes would be analysed according to the intention-to-treat principle. Kaplan-Meier method with the log-rank test will be used to compare differences in recurrent acute cholecystitis in 1 year. A health economic analysis will also be performed. Assuming a 17.1% difference in recurrent acute cholecystitis rates, a 2-sided P value of 0.05, a power of 80%, and a 10% dropout rate, 110 patients is required. Expected results The findings of this study can help establish the role of EUS-GBD in management of high-risk patients suffering from acute cholecystitis over antibiotics alone and Percutaneous transhepatic gallbladder drainage.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05893511
Study type	Interventional
Source	Chinese University of Hong Kong
Contact	Shannon Melissa Chan
Phone	35052627
Email	shannonchan@surgery.cuhk.edu.hk
Status	Recruiting
Phase	Phase 3
Start date	April 26, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04156711` - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery	N/A
Recruiting	`NCT02130245` - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study	N/A
Completed	`NCT01942356` - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor	N/A
Completed	`NCT04995380` - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed	`NCT03999645` - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days?	N/A
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03002051` - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent	N/A
Completed	`NCT00447304` - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy	Phase 3
Completed	`NCT04346550` - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain	N/A
Active, not recruiting	`NCT04197908` - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.	N/A
Completed	`NCT02027402` - Effects of Drainage in Laparoscopic Cholecystectomy	N/A
Not yet recruiting	`NCT01706068` - Transient ECG Changes in Patients With Acute Biliary Disease	N/A
Enrolling by invitation	`NCT04633512` - Safety and Feasibility of ActivSightTM in Human	N/A
Completed	`NCT04672902` - Treatment of Mirizzi Syndrome
Completed	`NCT03122054` - Early Versus Delayed Cholecystectomy	N/A
Recruiting	`NCT05732480` - Influence of Gut Microbiome in Gallstone Disease
Completed	`NCT04308265` - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting	`NCT06287112` - Prevention of Acute Cholecystitis With ETGBD	N/A
Recruiting	`NCT05709548` - Use of Indocyanine Green in Acute Cholecystitis	Phase 4
Not yet recruiting	`NCT06459323` - the Outcomes of Laparoscopic Cholecystectomy for Acute Cholecystitis Within and Beyond the First 72 Hours, Does it Differ?!	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.